Last reviewed · How we verify
NCT07218120: FIND-AD Aim 2
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
NA trial testing Financial Incentive in Memory Decline in 400 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 400 |
| Start date | 9 June 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Financial Incentive
- Active Comparator #1 — full drug profile →
Conditions studied
- Memory Decline — all drugs for Memory Decline →
- Healthy Subjects — all drugs for Healthy Subjects →
Sponsor
University of Southern California
Who can join
50 and older, any sex, with Memory Decline or Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to assess whether offering small $25 financial incentives can increase enrollment of diverse community members to the Alzheimer's Prevention Trial (APT) Webstudy, a memory concerns registry meant to accelerate clinical trials, relative to non-monetary incentives such as a reusable grocery bag. To do this we will test in-person recruitment efforts at community events and locations, such as Northgate Gonzalez Market locations and local food bank events. We also aim to compare the relative cost of recruiting an additional person to the APT Webstudy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07218120
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Financial Incentive
Trials testing the same drug.
- NCT06300242 — Incentives for Influenza Vaccination · NA · completed
- NCT06234371 — Financial Incentives for Veteran Therapy Completion · NA · enrolling by invitation
- NCT06133816 — Lung Cancer Screening Eligibility Assessment · NA · completed
- NCT05648773 — COVID-19 Booster Incentives · NA · completed
- NCT04328207 — Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits · NA · completed
Other recruiting trials for Memory Decline
Currently open trials in the same condition.
- NCT06933095 — Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia · NA · recruiting
- NCT07165977 — Anti-inflammatory Probiotics in Cognitive Functioning · NA · active not recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07218120 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 20 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07218120.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing